Understanding the contribution of cortical interneuron dysfunction to schizophrenia

了解皮质中间神经元功能障碍对精神分裂症的影响

• 批准号: MR/S010785/1
• 负责人: Oscar Marin
• 金额: $ 260.8万
• 依托单位: King's College London
• 依托单位国家: 英国
• 项目类别: Research Grant
• 财政年份: 2019
• 资助国家: 英国
• 起止时间: 2019 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=MR%2FS010785%2F1
• 关键词: Understanding; contribution; cortical; interneuron; dysfunction

Psychiatric disorders represent the leading source of disease burden in the developed world for people between ages 15 and 49. In contrast to heart disease or most forms of cancer, diseases such as autism or schizophrenia begin early in life and contribute to lifelong incapacity or reduced longevity. Consequently, psychiatric disorders are a great public health challenge. Current medications for most psychiatric disorders are merely palliative, largely because of our limited understanding of their causes. Schizophrenia is a complex developmental brain disorder with three main clusters of symptoms: (i) positive (psychosis, delusions and hallucinations), (ii) negative (reduced motivation and social withdrawal), and (iii) cognitive (memory and executive function deficits). Antipsychotic drugs control positive symptoms in some patients, but are ineffective in many, have a modest impact on negative symptoms, and fail to improve cognitive deficits. Consequently, the development of new therapies is an urgent unmet need.Multiple lines of evidence suggest that schizophrenia is a disorder of brain development caused by a combination of genetic factors and environmental stressors. Although advances in recent years have massively increased our understanding of genetic and environmental risks, we do not know how these factors converge during development to disrupt the function of specific brain circuits. In this context, the development of animal models for testing specific hypotheses on the mechanisms underlying schizophrenia is crucial, because achieving the required level of resolution in human studies is currently unfeasible.In this project, we aim to investigate how genetic and/or environmental disruption of the development of inhibitory circuits in the cerebral cortex may lead to the functional and behavioural alterations associated to schizophrenia. Our proposed research has three objectives:In Aim 1, we will investigate neural circuit abnormalities that may link different schizophrenia symptoms. It has been often assumed that different symptoms in schizophrenia may arise through independent alterations in different brain functions. We will carry out experiments to test the hypothesis that at least two of the main clusters of symptoms observed in schizophrenia might be caused by disruption of cortical inhibitory circuits. In Aim 2, we will analyse how cannabis use may impact the function of some of the cortical inhibitory circuits that are known to be particularly susceptible to pathological gene variation linked to schizophrenia. We will carry out these experiments in different developmental windows, which will allow testing how developmental timing influences pathological traits.In Aim 3, we will systematically explore gene networks linked to schizophrenia and probe their convergence on specific cortical inhibitory circuits. We will carry out bioinformatic and functional analyses to study genes whose variation has been linked to schizophrenia in humans and are expressed by specific populations of interneurons during the period that these cells develop their connections in the cerebral cortex.Identifying the neural circuits that are disrupted by pathological gene variation and environmental factors in schizophrenia is a fundamental step towards the development of novel therapeutical interventions that target the biological substrates of the disorder.

精神疾病代表了发达国家15至49岁人群的疾病负担的主要来源。与心脏病或大多数形式的癌症相比，自闭症或精神分裂症等疾病开始生命的早期，并导致终身无能或寿命减少。因此，精神疾病是一项巨大的公共卫生挑战。当前针对大多数精神疾病的药物仅仅是姑息治疗，这主要是因为我们对它们的原因有限。精神分裂症是一种复杂的发育性脑部疾病，具有三个主要症状簇：（i）正（精神病，妄想和幻觉），（ii）阴性（减少动机和社交戒断）以及（iii）认知（记忆和执行功能缺陷）。抗精神病药控制某些患者的阳性症状，但在许多患者中无效，对负面症状产生适度的影响，并且无法改善认知缺陷。因此，新疗法的发展是一种紧迫的需求。多种证据表明，精神分裂症是由遗传因素和环境压力源组合引起的大脑发育障碍。尽管近年来的进步已经大大增加了我们对遗传和环境风险的理解，但我们不知道这些因素在发育过程中如何融合以破坏特定脑电路的功能。在这种情况下，开发用于测试精神分裂症基础机制的特定假设的动物模型至关重要，因为目前无法达到人类研究中所需的解决水平。在这个项目中，我们旨在研究遗传和/或环境环境破坏脑疾病的抑制性电路的发展可能导致脑术与行为相关的行为行为。我们提出的研究有三个目标：在AIM 1中，我们将研究可能将不同精神分裂症症状联系起来的神经回路异常。人们通常认为，通过不同大脑功能的独立改变，精神分裂症的不同症状可能会引起。我们将进行实验，以检验以下假设：在精神分裂症中观察到的至少两个主要症状簇可能是由于皮质抑制回路的破坏引起的。在AIM 2中，我们将分析使用大麻的使用如何影响一些已知与精神分裂症相关的病理基因变异特别敏感的皮质抑制回路的功能。我们将在不同的发育窗口中进行这些实验，这将允许测试发展时机如何影响病理特征。在AIM 3中，我们将系统地探索与精神分裂症相关的基因网络，并探究其在特定皮质抑制回路上的收敛性。我们将进行生物信息学和功能分析，以研究其与人类精神分裂症有关的基因，并在这些细胞在这些细胞中发展其在大脑皮层中的连接的时期中由特定的中间神经元群体表达，并识别神经回路，该神经回路受到病理基因变异和环境因素的发展，这是构成基因的质量因素，而这些基因的构成了构造的构成构造的构成构成的因素。靶向该疾病的生物底物。

项目成果

Subcellular sorting of neuregulins controls the assembly of excitatory-inhibitory cortical circuits.

• DOI: 10.7554/elife.57000
• 发表时间: 2020-12-15
• 期刊: eLife
• 影响因子: 7.7
• 作者: Exposito-Alonso D;Osório C;Bernard C;Pascual-García S;Del Pino I;Marín O;Rico B
• 通讯作者: Rico B

Cortical wiring by synapse type-specific control of local protein synthesis

• DOI: 10.1126/science.abm7466
• 发表时间: 2022-11-25
• 期刊: SCIENCE
• 影响因子: 56.9
• 作者: Bernard, Clemence;Exposito-Alonso, David;Marin, Oscar
• 通讯作者: Marin, Oscar

Single-Nuclei RNA Sequencing of 5 Regions of the Human Prenatal Brain Implicates Developing Neuron Populations in Genetic Risk for Schizophrenia.

• DOI: 10.1016/j.biopsych.2022.06.033
• 发表时间: 2023-01-15
• 期刊: Biological psychiatry
• 影响因子: 10.6

Mechanisms Underlying Circuit Dysfunction in Neurodevelopmental Disorders

神经发育障碍中回路功能障碍的潜在机制

• DOI: 10.1146/annurev-genet-072820-023642
• 发表时间: 2022
• 期刊: Annual Review of Genetics
• 影响因子: 11.1
• 作者: Exposito-Alonso D